Please use this identifier to cite or link to this item:
http://cmuir.cmu.ac.th/jspui/handle/6653943832/77096| Title: | Single Dose Abacavir Pharmacokinetics and Safety in Neonates Exposed to Human Immunodeficiency Virus (HIV) |
| Authors: | Adrie Bekker Eric H. Decloedt Gretchen Slade Mark F. Cotton Helena Rabie Tim R. Cressey |
| Authors: | Adrie Bekker Eric H. Decloedt Gretchen Slade Mark F. Cotton Helena Rabie Tim R. Cressey |
| Keywords: | Medicine |
| Issue Date: | 1-Jun-2021 |
| Abstract: | Abacavir is a potential option for prophylaxis and early treatment of human immunodeficiency virus (HIV), but no data are available in neonates. Ten neonates administered a single abacavir dose of 8 mg/kg before 15 days of life had substantially higher exposures than those reported in infants and children, with no reported adverse events. |
| URI: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85107390423&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/77096 |
| ISSN: | 15376591 10584838 |
| Appears in Collections: | CMUL: Journal Articles |
Files in This Item:
There are no files associated with this item.
Items in CMUIR are protected by copyright, with all rights reserved, unless otherwise indicated.